Report: APIs to grow in Asia

The active pharmaceutical ingredient (API) industry in Asia/Pacific earned revenues of $1.12 billion in 2011 and is estimated to reach $1.79 billion in 2018, according to recent analysis by Frost & Sullivan. The growth will largely be due to Asia’s growing population and increasing incidence of life-style diseases, Frost & Sullivan says. “The focus on health care has enabled Australasia to corner a large share of the global pharmaceuticals market, compelling market majors to train their spotlight on emerging countries,” says Tridisha Goswami...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers